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Abstract: UHPLC-DAD-HRMS based dereplication guided the detection of new halogenated 
alkaloids co-produced by Talaromyces wortmannii. From the fungal growth in large scale, 
the epimers 2,8-dichlororugulovasines A and B were purified and further identified by means 
of a HPLC-SPE/NMR hyphenated system. Brominated rugulovasines were also detected  
when the microbial incubation medium was supplemented with bromine sources. Studies 
from 1D/2D NMR and HRMS spectroscopy data allowed the structural elucidation of the 
dichlorinated compounds, while tandem MS/HRMS data analysis supported the rationalization 
of brominated congeners. Preliminary genetic studies revealed evidence that FADH2 dependent 
halogenase can be involved in the biosynthesis of the produced halocompounds. 
  
OPEN ACCESS
Molecules 2015, 20 17628 
 
 
Keywords: halogenation; tryptophan; rugulovasine; dereplication; Talaromyces 
 
1. Introduction 
Natural compounds containing carbon–halogen bonds have been discovered for years but were often 
considered rare or isolated as artifacts in the past [1,2]. However, many halogenase enzymes from 
microorganisms have been identified and characterized. Presently, it is estimated that around 5000 
natural halometabolites have been discovered, with the alkaloids responsible for approximately 25% of 
these [1,3]. Since nitrogen-containing chemical structures are excellent platforms for biohalogenation, 
the discovery of new halogenated alkaloids is expected [3]. Their production is particularly highlighted 
in the marine environments due to the higher availability of the chloride and bromide species [4,5], 
even though terrestrial organisms including some fungi species were also described as organohalogens 
producers [6]. 
 
Figure 1. Chemical structures of the alkaloids produced by the T. wortmannii: (1) 
rugulovasine A; (2) rugulovasine B, (3) 8-chlororugulovasine A; (4) 8-chlororugulovasine B; 
(5) 2,8-dichlororugulovasine A; (6) 2,8-dichlororugulovasine B; (7) 2-bromorugulovasine A; 
and (8) 2-bromorugulovasine B. * Alkaloids reported for the first time. The depicted structures 
represent only relative configuration. 
The usage of exploratory strategies has increased notably within natural products research, including 
for instance, the ultrahigh performance liquid chromatography-diode array detection—high resolution 
mass spectrometry (UHPLC-DAD-HRMS) and tandem high resolution mass spectrometry (MS-HRMS) 
based dereplication [7,8]. Such approaches usually comprise dedicated data evaluation [9,10] but often 
result in successful and rapid identification of known compounds, revealing secondary metabolites  
still untapped [11–13]. In view of the foregoing outcomes, the metabolite screening of Talaromyces 
wortmannii (T. wortmannii) extracts was performed trough ultraviolet/visible (UV/Vis) and HRMS data 
analysis in combination with queries in commercial and in-house microbial databases. The strategy led 
to the identification of tryptophan-derived alkaloids, comprised of new halogenated rugulovasines 
(Figure 1). Rugulovasines are modified clavine alkaloids containing a singular spirolactone moiety [14], 
with toxic effects observed in day-old chickens [15,16]. These metabolites have been isolated as a racemic 
mixture [14,17] since they may interconvert upon warming through vinylogous Mannich reaction.  
Due to this chemical feature, they have also attracted interest in organic synthesis studies [18,19]. The first 
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occurrence of a halocompound derived from rugulovasines was reported by Cole in the 1970s [17] and 
so far, the new halogenated alkaloids produced by T. wortmannii are unique representatives to be reported 
since Cole’s discovery. 
Usually, the numbering of carbons into the ergot alkaloid backbone is established according to the 
original ergoline system [20]. Nevertheless, in their first report, the 8-chlororugulovasines were named 
from a different counting system [17], where the new halogenated rugulovasines were named on the 
basis of their known analogues. 
2. Results and Discussion 
The fungus T. wortmannii (CML 2704) was isolated from symptomless apple fruits (Malus domestica), 
following standard procedures for isolation of endophytic fungi [21]. Different growth media were 
tested for the incubation of the microorganism: PDA, CREA, MEA, CYA, DRYES, MEAox, WATM, 
YES and OA (for definitions see Section 3.5). The obtained micro-extracts had their metabolite screening 
carried out by UHPLC-DAD-QTOFMS (quadrupole time-of-flight mass detector) data analysis. A 
thorough investigation was applied from the observed accurate monoisotopic masses, fragment ions 
and adduct patterns, which assisted the finding of the elemental composition from the detected peaks in 
the base peak chromatograms (BPC). The found molecular formulas and accurate masses (±5 ppm) in the 
database AntiBase 2012 [22] as well as the use of a comprehensive microbial standard collection [9,10] 
were concomitantly applied along the data analysis process. Owing to the similar chemical profile 
exhibited in the chromatograms from the investigated micro-extracts, the PDA medium was chosen as 
the working growth medium and likewise for the results discussed hereafter. 
 
Figure 2. BPC chromatogram (100–1000 Da) from the micro-extract of T. wortmannii 
growth in PDA medium. Compounds identified by UV/Vis-HRMS based dereplication are 
indicated. (*) Isolated compounds. (**) compounds confirmed by comparison with reference 
standards. Peaks not highlighted have not been unambiguously identified. Data acquired at 
electrospray ionization in positive mode (ESI+), UHPLC-DAD-QTOFMS instrument. 
Among the hits retrieved by the database, the presence of multicolanic acid, (+)-mitorubrin,  
(−)-mitorubrinol, (+)-mitorubrinol acetate, skyrin, rugulosin, and rugulovasine A and B, was confirmed 
in the chromatograms by the comparison with the authentic reference standards. The overview from 
the confirmed AntiBase hits produced by T. wortmannii in PDA medium is shown in Figure 2. Still 
2 3 4 5 6 7 8 9 Time [min]0.0
0.2
0.4
0.6
0.8
6×10
Intens.
wortimannilactones(**)
rugulovasines 
A and B(**)
8-chlororugulovasines 
A and B(*) unknown 
compounds(*)
multicolanic acid(**)
rugulosin(**)
mitorubrinol(**)
mitorubrin(**)
mitorubrin 
acetate(**)
Molecules 2015, 20 17630 
 
 
including the main detected peaks, the 8-chlororugulovasines A and B were also found as likely records 
in the database. Since those compounds were not available in the standard collection, they were isolated 
from the scaled-up cultivation of the strain and confirmed on the basis of spectroscopic analysis, as 
will be further described. Apart from the identified compounds, two peaks eluted around 3.7 to 3.9 min 
in the BPC chromatogram (Figure 2), did not provide potential candidates, either in AntiBase or in the 
further literature queries. These observations led to the hypothesis of compounds biosynthesized by  
T. wortmannii still to be elucidated. 
2.1. Known and New Halogenated Rugulovasines Produced by T. wortmannii 
Besides the production of rugulovasine A and B by T. wortmannii, the dereplication process pointed 
towards the co-production of the halocongeners 8-chlororugulovasines A and B. This evidence was 
provided by the detection of the accurate masses m/z 303.0892 (−1.0 ppm) and 303.0896 (−0.3 ppm) 
(Figure S1), where the elementary compositions were given by the same formula C16H16O2N2Cl. The 
occurrence of halogenated compounds in the fungal micro-extracts was suggested not only by the 
likely detection of the known monochlorinated alkaloids but also due to the isotope pattern displayed 
by the two unknown ions detected at 3.7 and 3.9 min (Figure 3). Their accurate masses m/z 337.0506 
(−0.2 ppm) and 337.0507 (−0.6 ppm) afforded the molecular formula C16H15O2N2Cl2 for both, which, 
notably, matched to two additional chlorine atoms when compared to rugulovasines chemical composition 
(C16H17O2N2). Indeed, in accordance with the theoretical isotopic pattern found for the C16H15O2N2Cl2, 
the observed ions fitted to dichlorinated species. 
 
Figure 3. UV/Vis and full scan spectra of 2,8-dichlororugulovasine A and B produced by 
T. wortmannii in PDA incubation medium. (*) Magnified signal from pseudomolecular ion 
[M + H]+ and corresponding isotopes. Data acquired at ESI+, UHPLC-DAD-QTOFMS 
instrument. 
Moreover, similarly to the UV/Vis spectra from the rugulovasines and chlororugulovasines, the  
new compounds also showed a UV spectrum profile typical to tryptophan derivatives, with absorption 
maximums at nearly 225 and 295 nm (Figure S1). Altogether, these features indicated new alkaloids 
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potentially produced by the microorganism that were later identified as rugulovasine congeners,  
2,8-dichlororugulovasine A and 2,8-dichlororugulovasine B. 
Rugulovasines A and B as well as 8-chlororugulovasines A and B are reported as interconverting 
racemic forms favored by vinylogous Mannich type reaction [14,17,19]. Based on NMR and 
crystallography measurements, Cole and coworkers [17] established the absolute configuration of the 
rugulovasines series and further showed that in normal phase chromatography, stereoisomers A are 
more polar than stereoisomers B, likely due to the different conformations assumed by each structure. 
In other words, the antiperiplanar arrangement that the isomers A undergo, which is not achieved by the 
isomers B [18], can lead to particular physicochemical interactions with the stationary phase and likely 
cause earlier elution of the diasteroisomer A prior to B in reversed-phase chromatography. Based on 
this, we propose that the new dichlorinated rugulovasines A and B follow the same pattern and we thus 
assign the relative configuration of the first peak to A and the second to B, according to their retention 
in the reversed phase chromatographic systems used in our work. 
In order to isolate the 8-chlororugulovasines A and B and the new metabolites to confirm their 
chemical structures based on NMR and HRMS data analysis, the fungal strain was cultivated in large 
scale. The scaled-up extract was submitted to medium pressure chromatography, giving rise to enriched 
fractions in the target compounds. The final purification of the target alkaloids showed to be a laborious 
task due to the low yield of these metabolites when compared to the polyketides co-produced by the 
strain, and in particular the occurrence of signal broadening favored by the interconvertion of the 
isomers A and B. To overcome this, the most enriched fraction in the halometabolites was submitted to 
an automated coupled HPLC-SPE system with the sequential analysis by NMR with a cryogenic 
probehead. Along the chromatographic run, the compounds were trapped in polydivinylbenzene SPE 
cartridges, in a total of 30 sequential injections. 
Afterwards, the isolated compounds were then eluted from the SPE cartridges with methanol-d4 
before 1D and 2D NMR spectroscopy analysis. The NMR spectroscopic data allowed the identification of 
the known 8-chlororugulovasines A and B and the structural elucidation of the 2,8-dichlororugulovasine 
A and B (data are fully depicted in Figures S2–S31). The data set from the new dichlorinated alkaloids 
is summarized in Table 1, whereas from the known monochlorinated species are detailed in the 
Supplementary Material, Table S1. 
As expected, the 1H-NMR data analysis revealed a very similar chemical profile among the isolated 
compounds. In summary, the signals presented typical chemical shifts belonged to aromatic, vinylic, 
methylene and methyl systems, as well as NH indol nucleus. Although these sort of signals were 
similarly encountered for all metabolites, the absence of one singlet into the interval of δH = 7.17 and 
7.20 ppm was noteworthy when the 1H-NMR spectra from the new compounds was compared to the 
monohalogenated ones. In other words, by the overview from the magnified regions related to the 
deshielded nuclei (Figure 4), broad singlets were clearly observed for the 8-chlororugulovasines while 
they were not detected for the 2,8-dichlororuguvasines. These singlets were assigned to the vinyl 
protons belonged to the indole system from the monochlorinated analogues and hence this was the first 
evidence that pointed out the likely site for the second chlorine unit regarding the new structures. 
The key information was nonetheless given by the nuclei disposal at their aromatic system and by the 
couplings found for the remaining vinyl and methyl protons present in the unknown compounds backbone. 
The 1H spectra from the new metabolites (Figure 4a,b) exhibited the presence of two ortho-positioned 
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aromatic protons assigned by H-6 and H-7. Regarding the isomer B, they were represented by the  
pair of dublets at δH = 7.11 ppm and 6.74 ppm with coupling constant of J = 7.8 Hz, while the dublets 
δH = 7.11 ppm and 6.77 ppm with J = 7.8 Hz were clearly seen in 1H-NMR spectrum belonged to the 
epimer A. This result comprised not only the hydrogens placement in the aromatic ring system of the 
new metabolites, but also assisted with the confirmation of one chlorine atom attached to their C-8 
carbon nucleus, since the data from the 8-chlororugulovasines showed the same set of signals. 
Table 1. 1H-NMR and HMBC data (600 MHz, methanol-d4) of 2,8-dichlororugulovasine 
A and B. 
Position 
2,8-Dichlororugulovasine A 2,8-Dichlororugulovasine B 
δH (J in Hz) δC HMBC δH (J in Hz) δC * HMBC * 
1 8.09 (s) - - 8.09 (s) - - 
2 - 121.2 * - - 120.8 - 
3 - n.d. - - 106.3 - 
4 - 129.2 * - - 128.3 - 
5 - 125.9 * - - 125.0 - 
6 6.77 (d, 7.8) 117.7 C-4 *, C-8 * 6.74 (d, 7.8) 115.6 C-4,C-8, C-11 
7 7.11 (d, 7.8) 123.6 C-5 *, C-8 *, C-9 7.11 (d, 7.8) 122.0 C-5,C-8, C-9 
8 - 117.7 * - - 116.2 - 
9 - 131.8 * - - 130.8 - 
10a 3.21–3.28 (n.i.) * 23.2 * C-2 *, C-4 *, C-11 * 3.15–3.23 (n.i.) * 23.1 C-2, C-3, C-4 
   C-12*   C-12 
10b 2.89–2.92 (m) * 23.2 * - 2.90–2.97 (m) * 23.1 C-3, C-11 
11 3.21–3.28 (n.i.) * 63.4 C-12 * 3.15–3.23 (n.i.) * 63.05 C-12 
12 - 88.5 - - 88.7 - 
13 7.37 (br q, 1.4) 151.8 - 7.44 (br s) 150.4 - 
14 - 131.6 - - 130.5 - 
15 - 175.8 - - 174.1 - 
16 2.02 (d, 1.5) 11.4 C-13, C-14, C-15 1.98 (d, 1.5) 8.97 C-13, C-14, C-15 
17 2.44 (s) 35.6 C-11 2.42 (s) 33.60 C-11 
13C shifts obtained by the signal projection in the heteronuclear single quantum correlation (HSQC) and in 
the heteronuclear multiple quantum correlation (HMBC) spectra; * Signals and correlations obtained in the 
1H-NMR and HMBC spectra from 2,8-dichlororugulovasine A and B mixture; n.d.: signal not detected; n.i.: 
multiplicity not identified due to overlapping of solvent signal. 
Furthermore, the quadruplet observed at δH = 7.37 ppm (H-13) for the epimer A and the broad singlet 
at δH = 7.44 ppm (H-13) for epimer B allowed the proposal of an allylic group as part of the spiro 
system. The observed multiplicities suggested the coupling between the vinylic and methyl nuclei, while 
the correlations found in the HMBC spectrum from 2,8-dichlororugulovasine A indicated the attachment of 
these protons to the spiro ring. For instance, it was detected the correlation of CH3-16 (δH = 2.02 ppm) to 
the nuclei C-13 (δC = 151.8 ppm), as well as to C-14 (δC = 131.6 ppm) and C-15 (δC = 175.8 ppm). 
Another piece of information provided by HMBC data, showed the long-correlation of H-2 to the 
carbon C-9 from the indole scaffold of 8-chlororugulovasine A, whereas such nuclei interaction was not 
observed regarding the compound 2,8-dichlororugulovasine A (Figure S32). As a whole, the previous 
signal assignments precluded hereby the aromatic ring and the spiro system as the moieties for the 
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binding of the second expected chlorine atom. Therefore, the indol nucleus C-2 represented the remaining 
sp2 carbon most suitable for the halogenation. The same backbone disposal was confirmed to the isomer 
B, based on the same chemical profile obtained in 1H-NMR data (Table 1) and also the MS/HRMS data 
analysis showed hereafter. The signal assignments of isolated structures showed to be in agreement to 
the data previously reported for the rugulovasine congeners [15,17]. 
(a) 
(b) 
(c) 
(d) 
Figure 4. Amplified regions from the 1H-NMR spectra of (600 MHz, methanol-d4)  
(a) 2,8-dichlororugulovasine B; (b) 2,8-dichlororugulovasine A; (c) 8-chlororugulovasine B; 
and (d) 8-chlororugulovasine A. Region of vinylic protons is highlighted. 
2.2. Brominated Rugulovasines and MS/HRMS Data from the Co-Produced Rugulovasines 
Halogen atoms can be incorporated into organic compounds by enzyme-catalyzed reactions with 
halide ions [23]. However, the halogen binding is usually determined by the relative amount of halide 
present in the environment where the producer is submitted. For instance, the bromometabolites are most 
commonly biosynthesized by marine organisms, while chlorometabolites are predominately produced by 
terrestrial organisms [23,24]. Despite the fact that T. wortmannii has been isolated from apple fruits, 
the use of brominated additives into the potato dextrose (PD) medium culture was tested owing to verify 
the likely biosynthesis of brominated compounds by the strain. As a first attempt, the acid HBr was 
used alternatively to HCl for pH correction of culture media (final pH = 5.6). Separately, the second 
experiment employed the incorporation of KBr into the fermentation medium (2 mg/L), with no buffer. 
The obtained samples were then preliminarily analyzed via MS direct infusion (low-resolution data). 
Regarding the HBr addition into the incubation medium, the co-production of bromometabolites 
with rugulovasines congeners was readily apparent in the full scan spectrum of the corresponding extract 
(Figure 5). The diagnostic ions for the target alkaloids m/z 269, 303 and 337 were concomitantly detected 
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to the ions m/z 347 which displayed the typical isotope pattern of a monobrominated compound. 
Likewise, the same outcome was encountered for the experiment using KBr into the medium instead of 
HBr, as illustrated in Figure S33. The found nominal mass m/z 347 matched to 44 Da and 78 Da mass 
differences from the 8-chlororugulovasines and rugulovasines pseudomolecular ions, respectively, 
indicating the attachment of one bromine unit rather than one chlorine or one hydrogen atom to the 
unknown metabolite. Such observation was thus supported by the inspection of the UHPLC-HRMS 
data, which afforded the two peaks of accurate masses m/z 347.0389 (−0.1 ppm) and m/z 347.0388 
(−0.3 ppm) (Figure S34). Both ions had the molecular formula suggested by C16H16O2N2Br, which fit 
the acquired experimental and theoretical isotope patterns. 
 
Figure 5. Full scan spectrum of the crude extract obtained from T. wortmannii cultivated in PD 
medium with HBr as additive. Pseudomolecular ions from the co-produced rugulovasines and 
chlorinated analogues are highlighted in dashed line, while the brominated detected species 
is highlighted in continuous line. Data acquired at ESI+, triple quadrupole MS instrument. 
Therefore, the fungal extract supplemented with HBr was then submitted to MS/HRMS data analysis 
in view of establishing their fragmentation profile and to assist the characterization of the brominated 
chemical structures through the comparison with the compounds previously isolated. Differently  
from the dereplication process, the product ions experiment was carried out using HRMS instrument 
equipped with an Orbitrap mass analyzer (FTMS) whose the fully spectroscopic data are found in the 
Supplementary Material (Figures S35–S46). The common rugulovasine backbone was then confirmed 
for all co-produced alkaloids altogether, on the basis of the fragmentation pattern established by the 
detected accurate masses in their MS/HRMS spectra. The product ions that justify the rugulovasine 
scaffold are summarized in Table S2, while the plausible fragmentation mechanisms are detailed in 
Figure S49. Additionally, regarding the chlorinated and brominated species, the MS/HRMS data analysis 
also enabled the characterization of the halogenation sites into the tryptophan core and in particular the 
rationalization of the 2-bromorugulovasines structures. The product ions originated from the halogen 
losses are listed in Table 2 and are supported by proposed fragmentation mechanisms illustrated in 
Figure 6. 
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Figure 6. Plausible fragmentation mechanisms proposed to explain the product ions detected 
in the MS/HRMS spectra from (A) compounds 5–8; (B) compounds 3 and 4; and (C) 
compounds 1–8.  
From the pseudomolecular ions [M + H]+, the leaving of chlorine or bromine as radical species give 
rise to the product ions represented by I (Figure 6A, steps c1 and d1), while the exit of the halide group 
establish the ions represented by II (Figure 6A, steps c2 and d2). These losses lead to re-establishment 
of the aromatic system and are detected independently of the halocompound, although their occurrence 
might be justified trough distinct mechanisms. For example, to the 2,8-dichlororugulovasines and the 
2-bromorugulovasines pseudomolecular ions, it is assumed the leaving of the halogen connected to the 
nucleus C-2. This pathway comprises the tertiary carbocation, which supports the stability of the  
ions described by II in both cases. On the other hand, for the 8-chlororugulovasines (Figure 6B), the 
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electronic delocalization along the ergoline system is activated from the leaving of the proton belonged to 
the free amino group (step d2). The proposed mechanism affords the exit of the chlorine atom formerly 
attached to the nucleus C-8, maintaining the charge localized within the nitrogen moiety. In this case, the 
fragment ions indicated by II reach herein lower stability when compared to the species II generated 
from the halogenated structures at C-2, according to the relative intensities observed for them in Table 2. 
Table 2. Summary of accurate masses from the compounds 1–8 and their product ions 
(first line). Relative intensities based on from the base peak ion in the MS/HRMS spectra 
(second line). Elemental composition obtained from of each accurate masses (third line). 
Compound [M + H]+ 
Product Ions * 
(I) (II) (III) (IV) (V) 
(1) rugulovasine A  
269.1284 - - - - - 
(72%) - - - - - 
C16H17O2N2 - - - - - 
(2) rugulovasine B 
269.1284 - - - - 140.0705 
(37%) - - - - (8%) 
C16H17O2N2 - - - - C7H10O2N 
(3) 8-chlororugulovasine A 
303.0894 268.1208 267.1127 249.1022 - - 
(55%) (5%) (3%) (8%)   
C16H16O2N2Cl C16H16O2N2 C16H15O2N2Cl C16H13ON2 - - 
(4) 8-chlororugulovasine B 
303.0894 268.1205 267.1122 249.1021 - 140.0705 
(17%) (3%) (3%) (12%) - (17%) 
C16H16O2N2Cl C16H16O2N2 C16H15O2N2Cl C16H13ON2 - C7H10O2N 
(5) 2,8-dichlororugulovasine A 
337.0503 302.0814 301.0736 283.0631 255.0679 - 
(73%) (16%) (68%) (75%) (5%) - 
C16H15O2N2Cl2 C16H15O2N2Cl C16H14O2N2Cl C16H12ON2Cl C15H12N2Cl - 
(6) 2,8-dichlororugulovasine B 
337.0501 302.0812 301.0734 283.0628 255.0677 140.0703 
(35%) (5%) (27%) (33%) (6%) (18%) 
C16H15O2N2Cl2 C16H15O2N2Cl C16H14O2N2Cl C16H12ON2Cl C15H12N2Cl C7H10O2N 
(7) 2-bromorugulovasine A 
347.0388 268.1205 267.1128 249.1021 221.1072 - 
(37%) (13%) (21%) (11%) (5%) - 
C16H16O2N2Br C16H16O2N2 C16H15O2N2 C16H13ON2 C15H13N2 - 
(8) 2-bromorugulovasine A 
347.0387 268.1206 267.1128 249.1021 221.1072 140.0705 
(13%) (14%) (31%) (14%) (4%) (13%) 
C16H16O2N2Br C16H16O2N2 C16H15O2N2 C16H13ON2 C15H13N2 C7H10O2N 
Data acquired at ESI+, UHPLC- OrbitrapMS instrument. * Recorded at 25 eV. 
Along the step c6, the loss of CO unit encloses one new indol ring, supporting the species represented 
by IV. Those species are similarly observed to the new halometabolites but nonetheless absent in  
8-chlororugulovasines MS/HRMS data. Moreover, still taking into account the data summarized in 
Table 2, the detection of the product ions highlighted by V seemed to distinguish the epimeric forms A 
from B from the indole alkaloids produced by T. wortmannii. The spacial conformation assumed by the 
isomers B enables the retro Diels–Alder mechanism (Figure 6C), giving rise to the diagnostic fragment 
ion of m/z 141 (nominal mass). 
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2.3. Detection of the Halogenase Gene 
Enzymatic halogenation via hypohalite can be catalyzed using molecular oxygen as the oxidant with 
flavin as the redox active cofactor, in an enzimatic setting known as flavin adenine dinucleotide (FADH2) 
dependent halogenases [24,25]. It is known that FADH2 dependent halogenases expressed in prokaryotes 
are responsible for halogenation at C-5, C-6, C-7 and C-8 positions at indol moieties [26]. In contrast 
to prokaryotic systems, the halogenation of tryptophan is an unusual reaction in fungi. Even though the 
FADH2 dependent halogenases have been described in eukaryotic organisms, with high similarity to 
those found in bacteria, they seem to not comprise the same specificity. Biosynthetic cluster from radicicol, 
which has been isolated from some fungi containing putative halogenases (Cdr2 or radH), assisted to 
define how these enzymes can act in different metabolite cores [27,28]. Specific halogenating enzymes for 
C-8 and C-2 sites from tryptophan have already been exploited either. The enzymes RebH and CmdE, 
responsible for the halogenation at C-8 and C-2, respectively, in rebeccamycin and chondramida-D, are 
the main representatives for this type of reaction but still only better clarified in bacterial species [29,30]. 
Aiming to prove the unambiguous microbial origin of the new haloalkaloids isolated from  
T. wortmannii and verify if their biosynthesis is potentially conducted by FADH2 dependent halogenases, 
the strain was submitted to genomic analysis. The comparison from the reported data with amino acids 
sequences of halogenases produced by eukaryotic organisms, allowed the identification of four conserved 
and appropriate regions for the construction of four degenerate PCR primers (NCBI database). Using 
such primers over four combinations of genomic DNA from T. wortmannii as a template, a fragment 
of approximately 1134 kbp could be amplified in a combination of J5 and J7 primers (Section 3.10). 
The sequencing and analysis of the PCR product of 1.1 kbp showed identity between 35% and 45% 
halogenases described in NCBI database, from eukaryotic organisms. According to these data, the most 
outstanding result was obtained with the similarity alignment with radH halogenase amino acid sequence 
from Aspergillus oryzae, as it is also displayed in Figure S50. Despite the low identity in terms of 
percentage between the radH halogenase and the amino acid sequence obtained from T. wortmannii, 
the result still prints evidences concerning the occurrence of encoded halogenase in the genome of  
the fungus. Apparently, some regions of the PCR fragment sequence have introns, which may be one 
reason for the low level of similarity. Nevertheless, the GWXWXIPL region (Figure S50) is specific 
for confirming halogenases and considered to be a conserved region for all dependent halogenases of 
FADH2 [31]. This preliminary study did not enable the inference that halogenations in C-2 and C-8 
result from the activity of the same enzyme or perhaps from two different halogenases. However, the 
described results evince that the halogenation of the rugulovasines A and B precursors potentially occur 
by an enzymatic process. Based upon the detection of the amplified fragment described above, the 
ongoing work with the strain has focus on the isolation and the enzymatic activity of the halogenase to 
corroborate with the biosynthetic studies of the halorugulovasines from T. wortmannii. 
2.4. Antibacterial Assay 
The isolated compounds 8-chlororugulovasine A, 8-chlororugulovasine B and the new compound 
2,8-dichlororugulovasine A were tested against gram-negative bacteria Escherichia coli ATCC 25922. 
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Any meaningful response was observed for the tested concentrations. The obtained MIC for the 
tetracycline (used as control) was 3.9 μg/mL. 
3. Experimental Section 
3.1. Isolation, Identification, and Preservation of T. wortmannii 
The fungal strain was isolated from a sample of apple fruits (Malus domestica, Gala cultivar) purchased 
at a local market in São Carlos (São Paulo state, Brazil—January 2008). The fruits were washed with 
liquid soap under tap water and subjected to an adapted methodology for isolation of endophytes [21]. 
Disinfection of fruit surface was done by alternating immersions in 70% EtOH solution, H2O, 11% aq. 
NaClO solution, and H2O, for 1 min each. The fruits were then aseptically peeled, and fragments of 
pulp were transferred to Petri dishes containing potato dextrose agar (PDA, formulation in [32]) and 
incubated in the dark at 25 °C for one week. The Talaromyces strain grew from one pulp fragment and 
was purified by re-streaking on PDA. It produced restrict colonies of yellowish mycelium covered with 
masses of green conidia on standard mycological media (Figure S51). Microscopically, it produced 
biverticillate conidiophores having acerose phialides and spherical to ellipsoidal conidia, characteristic 
of the genus Talaromyces [33]. It was identified as Talaromyces wortmanii by sequencing of a fragment 
of the second major subunit RNA polymerase (RPB2) and comparison with reference sequences of 
Talaromyces species deposited in the Genbank [34]; followed by a phylogenetic analysis of Maximum 
Likelihood (Figure S52) conducted with Mega software [35]. The generated DNA sequence was 
deposited in the GenBank, accession number KT004676. The strain is currently preserved at −80 °C in 
the Coleção Micológica de Lavras (CML), Universidade Federal de Lavras, Lavras, Brazil, under the 
accession number CML 2704.  
3.2. Chemicals and Standards 
All employed solvents and chemicals were of analytical grade (Sigma-Aldrich, Steinheim, Germany, 
unless otherwise stated). For HRMS analysis, LCMS grade was used while HPLC grade solvent was 
applied during metabolites extraction and purification. H2O was purified in Milli-Q system (Millipore, 
Bedford, OH, USA). The used standards of fungal secondary metabolites were obtained from the  
in house microbial collection [9,10]. 
3.3. UHPLC-DAD-QTOF and UHPLC-Orbitrap Analysis  
The UHPLC-HRMS based dereplications were carried out in an Ultimate 3000 UHPLC system with 
DAD detector (Dionex, Sunnyvale, CA, USA) coupled to a maXis G3 quadrupole time-of-flight (QTOF) 
mass spectrometer (Bruker, Bremen, Germany). The spectrometer was equipped with an electrospray 
(ESI) source, operated at a resolution of 50,000 full width at half maximum (FWHM), with mass spectra 
recorded in the range 100–1000 Da with 5 scans per second. The acquired spectral data were calibrated 
using sodium formate automatically infused prior to each analytical run and providing a mass accuracy 
better than 1.5 ppm. Separation of 1 μL samples were performed at 40 °C on a RP Kinetex C18 column 
(100 × 2.1 mm, 2.6 μm, Phenomenex, Torrance, CA, USA) employing linear gradient of H2O/CH3CN 
(90:10 → 0:100, v/v, both buffered with 20 mM of FA) in 10 min at a flow rate of 0.4 mL/min. UV/Vis 
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spectra were collected at wavelengths from 200 to 700 nm. All micro-extracts were manually dereplicated 
with assistance of the software DataAnaysis 4.0 software (Bruker). The UHPLC-MS/HRMS analysis 
were performed through an Accela High Speed LC coupled to a LTQ Orbitrap Velos FT-MS 
(ThermoFisher Scientific, San Jose, CA, USA), equipped with an electrospray source (HESI-II) and 
operated at a resolution of 60,000 FWHM, with positive ionization and 25 eV at MS/HRMS mode. The 
chromatographic system was fitted with a RP Luna C18 column (150 × 4.6 mm, 5 μm, Phenomenex) 
applying H2O/CH3CN (80:20 → 0:100, v/v, both buffered with 20 mM of FA) in 15 min at a flow rate 
of 0.5 mL/min. The software Thermo Xcalibur 2.1 (ThermoFisher Scientific) was used to control the 
full system. 
3.4. LC-UV-SPE-NMR 
The LC-UV-SPE instrument comprised an Agilent 1200 series HPLC (Agilent Tecnologies,  
Santa Clara, CA, USA) equipped with a G1315D DAD detector and a G1329A autosampler. Hystar 
2.3 software (Bruker, Bremen, Germany) was used to control the LC system. The chromatography was 
directly coupled to an automatic cartridge exchanger (Bruker) equipped with a range of cartridges 
containing different stationary phases, where the flow was directed automatically. The NMR measurements 
were carried out on a Bruker Avance III instrument (14.1 Tesla/600 MHz, Bruker) fitted to an 
automatic sample changer and a TCI 5 mm triple resonance (1H/13C/15N) z-field gradient cryo-probe. 
The probe was fitted with an automatic tuning and matching unit and a Cryo-FIT converter for coupling 
to the LC-SPE system. 
3.5. Media Culture and Micro-Extractions  
For the screening process, the strain isolated from apple fruits was grown in potato dextrose agar 
(PDA), creatinine sucrose agar (CREA), malt extract agar (MEA), czapeck yeast autolysate agar (CYA), 
dichloran rose bengal yeast extract sucrose (DRYES), malt extract agar Oxoid® (MEAox), Wickerhams 
antibiotic test medium (WATM), yeast extract sucrose agar (YES) and oatmeal agar (OA). For medium 
formulations, see [32]. The fungus was three-point inoculated in each medium and incubated at 25 °C 
in the dark for 14 days. Five plugs (6-mm diameter) along the diameter of the fungal colony were cut out 
and extracted according to the micro-extraction method developed by Smedsgaard [36]. The applied 
extraction solvent was a mixture of MeOH–CH2Cl2–EtOAc (1:2:3 v/v/v) with 1% of FA. 
3.6. Scaled Up and Metabolites Extraction 
The PDA medium was chosen for the large-scale cultivation of T. wortmannii. Nevertheless, the 
fungal incubation on solid medium was switched to the growth within PD (potato/dextrose) liquid 
medium (Difco, Lawrence, PA, USA). pH = 5.6 was reached by using HCl solution (0.1 mol/L). Three 
PDA plugs from the strain (1 cm2) were aseptically transferred 30 Erlenmeyer flasks (500 mL) 
containing 125 mL of PD medium, previously sterilized for 15 min, 121 °C. After 14 days at 25 °C, 
the mycelium was separated by reduced pressure filtration and the liquid phase was submitted to 
liquid-liquid fractionation with EtOAc (3 × 500 mL). The mycelia were combined and crushed altogether 
with MeOH (4 × 500 mL). The extraction was kept during 12 h in the dark, under static conditions 
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with following vacuum filtration. The crude extracts from the EtOAc and MeOH extraction were 
obtained separately after drying. However, as the compounds of interest were detected in both crude 
extracts, they were then combined. The micro-extraction mixture of solvents was not applied during 
the extraction process in order to avoid the appearance of potential halogenated artifacts. 
3.7. Metabolites Purification 
The PD crude extract was subjected to CombiFlash chromatography system (Teledyne Isco, Lincoln, 
NE, USA), fitted to a RP C18 column (100 g, 87.7 mL, Teledyne Isco), after which the linear gradient of 
H2O/MeOH (70:30 → 0:100, v/v)  was applied in 20 min with the flow rate of 40 mL/min. This process 
provided the fractions Fr1–Fr15. The fractions Fr8 and Fr9 were combined and refractionated on RP 
C18 column (30 g, 26.4 mL, Teledyne Isco) using the gradient H2O/MeOH (60:40 → 0:100, v/v) in 25 min 
with flow rate of 20 mL/min, which afforded the subfractions Fr16–Fr28. The subfraction Fr20 was 
injected in a preparative HPLC SIL-20AP VP (Shimadzu, Kyoto, Japan) with phenyl–hexyl column 
(250 × 21.20 mm, Phenomenex) applying the gradient of H2O/ACN (70:30 → 40:60, v/v) in 20 min, 
flow rate 14 mL/min. The samples Fr29–Fr40 were obtained and the sample Fr32 showed to be 
enriched in the halocompounds whose yield was 2.5 mg. This amount was then dissolved in 1.5 mL of 
H2O/MeOH (v/v) and filtered through a PVDF membrane syringe filter prior to the injection into the 
LC-UV-SPE-NMR system.  
The chromatographic separation was performed on a Luna C18 column (150 × 4.60mm, 5 µm, 
Phenomenex) with the gradient elution of linear gradient of H2O/ACN (80:20 → 40:60, v/v, both buffered 
with 5 ppm of TFA) in 20 min with a flow rate of 1.0 mL/min. The peaks of interest were detected through 
the UV absorbance at 285 nm and adsorbed on SPE cartridges (HySphere Resin GP-polydivinylbenzene, 
10 mm × 2 mm, 10 μm). Thirty consecutive chromatographic runs were performed, with volume 
injections of 20 μL. After the trapping process, the cartridges were dried with nitrogen for 30 min to 
remove residual solvent. Methanol-d4 (99.8% D) was used to elute the compounds from the SPE 
cartridges directly into 3 mm NMR tubes. 
3.8. Investigation of Brominated Compounds Produced by T. wortmannii 
In order to verify the potential biosynthesis of brominated compounds by the microorganism two 
different experiments were carried out in triplicate. The first test was performed through the use of HBr 
solution (0.01 mol/L) instead of HCl for pH correction of the liquid culture medium (pH = 5.6). The second 
experiment comprised the addition of KBr salt at the concentration of 0.2 mg/L into the fermentation 
medium with no buffer use. The strain incubation and the crude extract was performed as established 
in Section 3.6. The triplicate samples were redissolved in methanol (0.1 mg/mL), filtered and subjected 
to LC-MS (2 µL injection vol.) or alternatively to UHPLC-HRMS analysis (0.2 µL injection vol.). 
3.9. Antibacterial Assay 
The activity assay was performed against E. coli ATCC 25922 applying microbroth dilution assay 
as recommended by Clinical Laboratory Standards Institute CLSI (former NCCLS) [37]. The tested 
bacteria were incubated in the MH broth. The assays were performed on 96-well plates, in triplicate for 
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each tested compound, in the concentrations of 250, 125, 62.5, 31.2, 15.6, 7.8 and 3.9 µg/mL. Bioactivity 
was recorded as blue coloration in the wells accordingly the cells viability after resazurin dye  
reaction. Tetracycline was used as positive control and pure DMSO (Merck, Darmstadt, Germany) as 
negative control. 
3.10. PCR Amplification 
Degenerated oligonucleotides were designed to locate the halogenase gene in total DNA of  
T. wortmannii. They were derived from four conserved motifs present in the amino acid sequences of 
known eukaryotic halogenases proteins. These oligonucleotides were used to attempt PCR amplification 
using total DNA from T. wortmannii as the template. The sequences of two sense oligonucleotides were 
J5 5′-GTGGTTGGTGGTGGCCCTGGAGGG-3′, J6 5′-TCGACCGCTGGCATCGACCAA-3′, J7 5′-TGG 
GCATGGTTCATTCCTCTCCACAAC-3′ and J8 5′-CCCAGATGAGAAGAATGGGTCAATGAA-3′. 
PCR mixtures contained 50 ng of template DNA, 50 pmol of each primer, 1 mM MgCl2, 2.5 U Taq DNA 
Polymerase (MBI Fermentas), 2.5% DMSO and 0.2 mM dNTP-mix. Amplification was obtained by 
standard procedure with an annealing temperature of 50 °C. 
4. Conclusions 
UHPLC-HRMS based dereplication conducted the detection of unknown halocompounds biosynthesized 
by T. wortmannii, a fungus isolated from symptomless apple fruits. The 2,8-dichlororugulovasine A and 
B were purified from the fungal growth in PD medium while the 2-bromorugulovasine A and B were 
observed as co-products when inorganic additives were used into the incubation medium. The dichlorinated 
compounds had the structural elucidation supported by NMR 1D/2D spectroscopy combined to 
accurate full-scan HRMS and MS/HRMS data, while the bromine derivatives were identified exclusively 
by means of thorough tandem MS/HRMS data analysis. 
The likely occurrence of FADH2 dependent halogenases in T. wortmannii enzymatic system was also 
proposed based on the detection of one conserved region for halogenases within the organism gene 
code. Halogenation in secondary metabolites produced by fungi occurs mostly in phenolic substrates, 
although tryptophan had been encountered as free substrate for halogen incorporation for instance in  
8-chlororugulovasines from Penicillium islandicum [17] and some brominated roquefortines from 
Penicillium chrysogenum [38].  
The reaction at indol system is well known in prokaryotic organisms whereas particularly at C-2 
from tryptophan core is uncommon either in bacteria or fungal species. As a whole, halogenations 
seem to be less expressed within fungal enzymatic systems or perhaps less exploited due to the access to 
microorganisms, which encode such enzymes. In Antibase 2012 [22] for example, there are 22 entries 
for fungal compounds derived from tryptophan, which own one or more chlorinated sites, while only 
three hits are encountered for brominated indol moiety and any case is included involving fluorine or iodine 
as substituents. In view of these observations, the production of the new chlorinated and brominated 
alkaloids by T. wortmannii is a meaningful case to be further explored, taking into account the elucidation 
of biosynthetic pathways involving biohalogenations from filamentous fungi and mainly to boost the 
discovery of other untapped halometabolites from terrestrial microorganisms. 
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